A Promising Potential Drug Target: YBX3P1 (CSDAP1) (G440359)

Target Name: YBX3P1

NCBI ID: G440359

YBX3P1

Other Name(s): CSDAP1 | Y-box binding protein 3 pseudogene 1

A Promising Potential Drug Target: YBX3P1 (CSDAP1)

Introduction

YBX3P1 (CSDAP1), a gene encoding a protein known as CSDAP1, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric conditions. Its unique structure and function have piqued the interest of researchers, leading to a growing body of research to investigate its potential clinical applications. In this article, we will delve into the science behind YBX3P1, its potential drug targets, and its potential as a biomarker for various diseases.

The CSDAP1 Protein and Its Functions

CSDAP1, or cytoplasmic protein SAP1, is a protein that plays a crucial role in cell-cell adhesion and cytoskeletal organization. It is a member of the family of cytoplasmic proteins known as the SAP family, which includes other proteins involved in cell-cell adhesion , such as SAP90 and SAP125.

CSDAP1 is involved in numerous cellular processes, including the regulation of cell adhesion, the formation of tight junctions, the regulation of mitochondrial fusion, and the regulation of actin dynamics. It is a glycoprotein with a molecular weight of approximately 180 kDa and a pre- fusion dwell time (PFPT) of 15 seconds.

In addition to its functions in cytoskeletal organization and cell-cell adhesion, CSDAP1 has also been shown to play a role in various signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cell proliferation, survival, and angiogenesis, and is a potential target for various pharmaceuticals, including anti-cancer agents.

Potential Drug Targets

The CSDAP1 protein is a potential drug target due to its unique structure and function. Its cytoplasmic localization and the presence of a pre-fusion dwell time (PFPT) suggest that it is involved in processes that are essential for cellular survival and growth.

Several studies have identified potential drug targets based on CSDAP1. One of these targets is the CSDAP1-Tyrosine Interface, which is involved in the regulation of cell adhesion and cytoskeletal organization. Activation of this interface has been shown to promote cell-cell adhesion and contribute to the development of various diseases, including cancer.

Another potential drug target is the CSDAP1-Centrosome Interface, which is involved in the regulation of mitochondrial fusion and the regulation of actin dynamics. Disruptions in this interface have been linked to a variety of neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease.

Potential Biomarkers

CSDAP1 has also been identified as a potential biomarker for various diseases. Its unique structure and function make it an attractive candidate for diagnostic tools and therapeutic targets.

One potential biomarker for cancer is the expression of CSDAP1, which has been shown to be upregulated in various types of cancer, including breast, lung, and ovarian cancer. This increased expression of CSDAP1 has been shown to contribute to the development and progression of these diseases.

Another potential biomarker for neurodegenerative disorders is the presence of CSDAP1 in the brains of individuals with Alzheimer's disease and Parkinson's disease. This suggests that CSDAP1 may be involved in the development and progression of these disorders.

Conclusion

In conclusion, CSDAP1 is a protein with unique structure and function that has the potential to be a drug target for various diseases. Its involvement in the regulation of cell-cell adhesion, cytoskeletal organization, and signaling pathways makes it an attractive candidate for intervention. Its potential as a biomarker for cancer and neurodegenerative disorders adds to its growing list of potential clinical applications. Further research is needed to fully understand the role of CSDAP1 in disease and to develop safe and effective drugs that target this protein.

Protein Name: Y-box Binding Protein 3 Pseudogene 1

The "YBX3P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about YBX3P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets